Warning: This security is no longer trading.
defunct
Akcea Therapeutics, Inc. (AKCA): Price and Financial Metrics
AKCA Price/Volume Stats
| Current price | $18.17 | 52-week high | $21.70 |
| Prev. close | $18.14 | 52-week low | $8.00 |
| Day low | $18.13 | Volume | 815,300 |
| Day high | $18.17 | Avg. volume | 361,806 |
| 50-day MA | $15.31 | Dividend yield | N/A |
| 200-day MA | $15.48 | Market Cap | 1.85B |
AKCA Stock Price Chart Interactive Chart >
Akcea Therapeutics, Inc. (AKCA) Company Bio
Akcea Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. The company was founded in 2014 and is based in Cambridge, Massachusetts.
AKCA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -3.48% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -43.80% |
Continue Researching AKCA
Want to do more research on Akcea Therapeutics Inc's stock and its price? Try the links below:Akcea Therapeutics Inc (AKCA) Stock Price | Nasdaq
Akcea Therapeutics Inc (AKCA) Stock Quote, History and News - Yahoo Finance
Akcea Therapeutics Inc (AKCA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...